发明公开
- 专利标题: QUINAZOLINONE ANTIBIOTICS
- 专利标题(中): 喹唑啉酮抗生素
-
申请号: EP14760020.9申请日: 2014-03-05
-
公开(公告)号: EP2964618A1公开(公告)日: 2016-01-13
- 发明人: CHANG, Mayland , MOBASHERY, Shahriar , BOULEY, Renee
- 申请人: University Of Notre Dame Du Lac
- 申请人地址: 171 Fitzpatrick Hall Notre Dame, Indiana 46556-5637 US
- 专利权人: University Of Notre Dame Du Lac
- 当前专利权人: University Of Notre Dame Du Lac
- 当前专利权人地址: 171 Fitzpatrick Hall Notre Dame, Indiana 46556-5637 US
- 代理机构: O'Connell, Maura
- 优先权: US201361851310P 20130305
- 国际公布: WO2014138302 20140912
- 主分类号: C07D239/91
- IPC分类号: C07D239/91 ; C07D401/02 ; C07D403/02 ; C07D407/06 ; C07D413/02 ; A61K31/517 ; A61K31/519 ; A61P31/04
摘要:
A new class of antibiotics effective against methicillin-resistant Staphylococcus aureus (MRSA) is disclosed. Compounds of this class can impair cell-wall biosynthesis by binding to both the allosteric and the catalytic domains of penicillin-binding protein (PBP) 2a. This class of antibiotics holds promise in reversing obsolescence of staphylococcal PBPs as important targets for antibiotics. Embodiments of the invention thus provide novel antibacterial compounds that target penicillin-binding proteins and/or other important cellular targets. Methods for inhibiting the growth and/or replication of bacteria using the compounds described herein are also provided. Various embodiments exhibit activity against gram positive bacteria, including drug-resistant strains of Staphylococcus aureus.
公开/授权文献
- EP2964618B1 QUINAZOLINONE ANTIBIOTICS 公开/授权日:2019-09-04
信息查询